Drawing for ACCREDO HEALTH GROUP, INC.

USPTO serial 78942483

ACCREDO HEALTH GROUP, INC.

Reviewed by CopyMark Law Group

Reg. 3249469Status 710
Filing date
Status date
Registration date
Jun 5, 2007
Examiner
ROSSMAN, MARY
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ACCREDO HEALTH GROUP, INC.?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Arkadia DeLay Olson

Arkadia DeLay Olson Husch Blackwell LLP190 Carondelet Plaza, Suite 600St. Louis, MO 63105UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of chronic diseases, namely, alpha-1 antitrypsin deficiency, moderate to severe persistent asthma, pulmonary arterial hypertension, respiratory syncytial virus, chronic, moderate to severe plaque psoriasis, hereditary tyrosinemia type 1, autoimmune disorders and primary immune deficiencies, growth hormone deficiency, Fabry disease, rheumatoid arthritis, psoriatic arthritis, hemophilia, Gaucher disease, blepharospasm, cervical dystonia, hyperhidrosis, strabimus, multiple sclerosis, hypomobility associated with advanced Parkinson's disease, MPS 1, severe combined immunodeficiency disease, chronic granulomatour disease, severe malignant osterpetrosis; pharmaceutical preparations for use as blood clotting agents used in the control of hemophiliaSECTION 8 - CANCELLEDApr 3, 2006
035Retail pharmacy services specializing in the control of chronic diseases; retail pharmacy services specializing in the control of hemophiliaSECTION 8 - CANCELLEDMar 31, 2006
044Nursing care specializing in the treatment, prevention and control of chronic diseases; nursing care specializing in the treatment, prevention and control of hemophilia; medical services, namely, administration of pharmaceutical preparations used in the treatment of chronic diseases and administration of pharmaceutical preparations used in the treatment of hemophiliaSECTION 8 - CANCELLEDJul 21, 2006

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 10, 2014C8..CANCELLED SEC. 8 (6-YR)—
Oct 16, 2013ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 16, 2013REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 17, 2007TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 5, 2007R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 20, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 28, 2007NPUBNOTICE OF PUBLICATION—
Feb 1, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 1, 2007ALIEASSIGNED TO LIE—
Dec 29, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 29, 2006XAECEXAMINER'S AMENDMENT ENTERED—
Dec 29, 2006GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 29, 2006CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 26, 2006DOCKASSIGNED TO EXAMINER—
Aug 5, 2006MDSCNOTICE OF DESIGN SEARCH CODE MAILED—
Aug 4, 2006NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance